| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4798107
Max Phase: Preclinical
Molecular Formula: C16H15ClN6
Molecular Weight: 326.79
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Nc1nc(Cl)nc2c1ncn2Cc1cccc(C2=CCCC2)n1
Standard InChI: InChI=1S/C16H15ClN6/c17-16-21-14(18)13-15(22-16)23(9-19-13)8-11-6-3-7-12(20-11)10-4-1-2-5-10/h3-4,6-7,9H,1-2,5,8H2,(H2,18,21,22)
Standard InChI Key: AEVOGTRECSERJK-UHFFFAOYSA-N
Associated Targets(Human)
Phosphodiesterase 8A 260 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 326.79 | Molecular Weight (Monoisotopic): 326.1047 | AlogP: 3.07 | #Rotatable Bonds: 3 |
| Polar Surface Area: 82.51 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.32 | CX LogP: 2.98 | CX LogD: 2.98 |
| Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -0.75 |
References
| 1. Huang Y,Wu XN,Zhou Q,Wu Y,Zheng D,Li Z,Guo L,Luo HB. (2020) Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors., 63 (24): [PMID:33291877] [10.1021/acs.jmedchem.0c01573] |
Source
Source(1):